Vertical Aerospace arrives at its September 11 annual meeting with its shares around $0.60, its 30-trading-day average below the NYSE’s $1 minimum-price threshold for the second time in two years, certification pushed to 2029 and currently accessible financing carrying operations only through the third quarter of 2027. That is not a cosmetic stock-market problem. Vertical still needs substantial capital before certification, and major parts of the financing machinery keeping the company alive depend on its shares remaining listed on the NYSE or another major US exchange. Actual delisting would shut down the up to $500 million Yorkville standby equity facility as currently written and would worsen the terms of its preferred financing. Six weeks ago Vertical was demonstrating a genuine engineering achievement at Farnborough. On September 11 shareholders confront the harder fact: customers are still not financing the company, and the public stock itself is part of the system required to keep it alive.
September 11 is not a delisting date. A minimum-price deficiency starts a cure process, and Vertical could restore compliance through a share-price recovery or another reverse split. The date matters because the listing problem, the funding gap and the changing control structure are converging at the same meeting. The AGM circular asks shareholders to increase the employee incentive share pool, reprice outstanding employee options from $3.50 or $5.82 to $1.30, and incorporate stronger director nomination, removal and consent rights for Mudrick Capital, Vertical’s largest shareholder and senior secured lender. Common shareholders are once again facing an exchange-compliance problem while a creditor whose capital has become essential gains greater formal influence over the company.